CSIMarket


Cryo cell International Inc  (CCEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

CCEL's Operating Income Growth by Quarter and Year

Cryo Cell International Inc's Operating Income results by quarter and year




CCEL Operating Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter November - 2.48 1.99 0.92
III Quarter August 1.60 1.75 0.50 1.15
II Quarter May 2.00 1.25 0.85 0.99
I Quarter February 1.24 1.72 2.13 1.25
FY   4.84 7.20 5.47 4.31



CCEL Operating Income third quarter 2021 Y/Y Growth Comment
Cryo Cell International Inc reported decrease in Operating Income in the third quarter by -8.78% to $ 1.60 millions, from the same quarter in 2020.
The decrease in the third quarter Cryo Cell International Inc's Operating Income compares unfavorably to the Company's average Operating Income jump of 69.56%.

Looking into third quarter results within Medical Laboratories industry 9 other companies have achieved higher Operating Income growth. While Cryo Cell International Inc' s Operating Income decline of -8.78% ranks overall at the positon no. 1944 in the third quarter.

Explain Operating Income growth


CCEL Operating Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter November - 24.62 % 116.3 % -36.55 %
III Quarter August -8.78 % 250 % -56.52 % -3.36 %
II Quarter May 60 % 47.06 % -14.14 % -11.61 %
I Quarter February -27.91 % -19.25 % 70.4 % 171.74 %
FY   - 31.63 % 26.91 % 2.13 %

Financial Statements
Cryo Cell International Inc's third quarter 2021 Operating Income $ 1.60 millions CCEL's Income Statement
Cryo Cell International Inc's third quarter 2020 Operating Income $ 1.75 millions Quarterly CCEL's Income Statement
New: More CCEL's historic Operating Income Growth >>


CCEL Operating Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter November - 41.71 % 298 % -20 %
III Quarter August -20.18 % 40 % -41.18 % 16.16 %
II Quarter May 61.29 % -27.33 % -60.09 % -20.8 %
I Quarter February -50 % -13.57 % 131.52 % -13.79 %
FY (Year on Year)   - 31.63 % 26.91 % 2.13 %




Operating Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #10
Healthcare Sector #146
Overall #1944

Operating Income Y/Y Growth Statistics
High Average Low
613.54 % 69.56 % -74.98 %
(Feb 28 2017)   (Feb 29 2016)
Operating Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #10
Healthcare Sector #146
Overall #1944
Operating Income Y/Y Growth Statistics
High Average Low
613.54 % 69.56 % -74.98 %
(Feb 28 2017)   (Feb 29 2016)

Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Cryo Cell International Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
555.8 % 63.17 % -84.22 %
(Aug 31 2013)  


CCEL's III. Quarter Q/Q Operating Income Comment
In the III. Quarter 2021 Cryo Cell International Inc disclosed fall in Operating Income from the second quarter by -20.18% to $ 1.60 millions, from $ 2.00 millions achived in the previous quarter.

Those cyclical factors which commonly elevate III. Quarter 2021 results, could not salvage the III. Quarter for the Cryo cell International Inc, Hedvig Johansson, an industry expert situated in Stockholm pointed out and wrote that average quarter on quarter Operating Income growth is at 63.17% for CCEL.

Within Medical Laboratories industry 12 other companies have achieved higher Operating Income quarter on quarter growth. While Cryo Cell International Inc's Operating Income growth quarter on quarter, overall rank is 1812.


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #13
Healthcare Sector #140
Overall #1812
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #13
Healthcare Sector #140
Overall #1812
Operating Income Q/Q Growth Statistics
High Average Low
555.8 % 63.17 % -84.22 %
(Aug 31 2013)  


CCEL's III. Quarter Q/Q Operating Income Comment
In the III. Quarter 2021 Cryo Cell International Inc disclosed fall in Operating Income from the second quarter by -20.18% to $ 1.60 millions, from $ 2.00 millions released in the previous reporting period.

Even seasonal influence which commonly fuel III. Quarter 2021 Operating Income, this clearly was not sufficient to recover Medical Laboratories's company achievement, Hedvig Johansson, an industry expert situated in Stockholm wrote and wrote that average sequential Operating Income growth is at 63.17% for the Medical Laboratories's company.

Within Medical Laboratories industry 12 other companies have achieved higher Operating Income quarter on quarter growth. While Cryo Cell International Inc's Operating Income growth quarter on quarter, overall rank is 1812.


Cryo Cell International Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Aug 31 2021)
12 Months Ending
(May 31 2021)
12 Months Ending
(Feb 28 2021)
12 Months Ending
(Aug 31 2020)
12 Months Ending
(May 31 2020)
Cumulative Operating Income 12 Months Ending $ 7.31 $ 7.46 $ 6.72 $ 7.20 $ 5.49
Y / Y Operating Income Growth (TTM) 8.83 % 36.73 % 32.67 % 31.51 % 8.61 %
Year on Year Operating Income Growth Overall Ranking # 1087 # 26 # 14 # 10 # 796
Seqeuential Operating Income Change (TTM) -2.09 % 11.11 % -6.72 % 7.26 % 19.57 %
Seq. Operating Income Growth (TTM) Overall Ranking # 1409 # 107 # 46 # 18 # 469




Cumulative Operating Income growth Comment
With the quarterly Operating Income reported in the Aug 31 2021 period, Cryo Cell International Inc's cumulative twelve months Operating Income were $ 7 millions, company would post below average annual Operating Income growth of 19.57% year on year, if the fiscal year would end at Aug 31 2021.
A slow-down in the Cryo Cell International Inc's Operating Income growth from the 2% growth in May 31 2021.

In the Healthcare sector 81 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 26 to 1087.

Operating Income TTM Q/Q Growth Statistics
High Average Low
221.34 %
13.34 %
-65.06 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 8
Healthcare Sector # 82
Overall # 1087

Operating Income TTM Y/Y Growth Statistics
High Average Low
1054.59 %
64.82 %
-83.8 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 102
S&P 500 # 1409
Cumulative Operating Income growth Comment
With the quarterly Operating Income reported in the Aug 31 2021 period, Cryo Cell International Inc's cumulative twelve months Operating Income were $ 7 millions, company would post below average annual Operating Income growth of -83.8% year on year, if the fiscal year would end at Aug 31 2021.
A slow-down in the Cryo Cell International Inc's Operating Income growth from the 2% growth in May 31 2021.

In the Healthcare sector 81 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 26 to 1087.

Operating Income TTM Q/Q Growth Statistics
High Average Low
221.34 %
13.34 %
-65.06 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 8
Healthcare Sector # 82
Overall # 1087

Operating Income TTM Y/Y Growth Statistics
High Average Low
1054.59 %
64.82 %
-83.8 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 102
S&P 500 # 1409




Other Operating Income Growth
Medical Laboratories Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
CCEL's Operating Income Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for CCEL's Competitors
Operating Income Growth for Cryo Cell International Inc's Suppliers
Operating Income Growth for CCEL's Customers

You may also want to know
CCEL's Annual Growth Rates CCEL's Profitability Ratios CCEL's Asset Turnover Ratio CCEL's Dividend Growth
CCEL's Roe CCEL's Valuation Ratios CCEL's Financial Strength Ratios CCEL's Dividend Payout Ratio
CCEL's Roa CCEL's Inventory Turnover Ratio CCEL's Growth Rates CCEL's Dividend Comparisons



Companies with similar Operating Income fall for the quarter ending Aug 31 2021 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Aug 31 2021
Cryo cell International Inc-35.64%$ -35.637 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VTAQ's Profile

Stock Price

VTAQ's Financials

Business Description

Fundamentals

Charts & Quotes

VTAQ's News

Suppliers

VTAQ's Competitors

Customers & Markets

Economic Indicators

VTAQ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071